032sek
-7,4 %
Date:2025-12-01Time:18:00:00Latest report:Q3-2025List:NGMTicker:LEVBIO
Market Cap:22 msekEnterprise Value:21 msekNet Sales:30,4 msekEarnings:-3,81 msekEmployees:0ISIN:SE0000885501

Ratios

10-year key figure history for Level Bio turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Level Bio with index and moving average MA50 and MA200.

Stockprice:0,32
MA50:0,36
MA200:0,34
Price/MA200:-6,0 %
RSI (14):46,2
Price/MA50:-10,1 %

Description

Level Bio operates in the medical technology sector. The company conducts research and development of patented technology that enables the identification of viruses and bacteria. The products are sold under several brands and through its own distributors, mainly to laboratories and research institutes. The largest operations are found in the Nordic market. The headquarters are located in Nacka.

Medical Equipment